Almirall, S.a.
Clinical trials sponsored by Almirall, S.a., explained in plain language.
-
New injection tested to regrow hair in severe alopecia
Disease control Recruiting nowThis study is testing an investigational drug called LAD603 to see if it helps regrow hair in adults with severe to very severe alopecia areata, an autoimmune condition that causes hair loss. About 136 participants will receive either LAD603 or a placebo injection to compare hair…
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
First human tests begin for new drug candidate
Knowledge-focused Recruiting nowThis is an early safety study testing a new drug called LAD106 in healthy volunteers. The main goal is to see how safe the drug is, how the body processes it, and what side effects might occur. Researchers will test different single and multiple doses in small groups of healthy a…
Phase: PHASE1 • Sponsor: Almirall, S.A. • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC